Edwards Lifesciences Corp. (EW)

152.87
0.69 0.45
NYSE : Health Technology
Prev Close 152.18
Open 152.77
Day Low/High 151.76 / 154.10
52 Wk Low/High 100.20 / 155.22
Volume 1.07M
Avg Volume 1.37M
Exchange NYSE
Shares Outstanding 210.78M
Market Cap 32.44B
EPS 2.80
P/E Ratio 59.19
Div & Yield N.A. (N.A)

Latest News

Tech Alone Can't Save the Rally: Cramer's 'Mad Money' Recap (Tuesday 6/5/18)

Tech Alone Can't Save the Rally: Cramer's 'Mad Money' Recap (Tuesday 6/5/18)

Jim Cramer says the tech titans are leading the way, but out side of the tech sector, very few stocks are following.

Hasbro, Dropbox, Carlyle Group: 'Mad Money' Lightning Round

Hasbro, Dropbox, Carlyle Group: 'Mad Money' Lightning Round

Jim Cramer weighs in on Hasbro, Dropbox, Carlyle Group, Corning, Banco Santander, Goldman Sachs, Edwards Lifesciences, J. Jill and more.

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

9 Stocks Poised to Change Direction: Guess Which Way UPS Is Headed?

9 Stocks Poised to Change Direction: Guess Which Way UPS Is Headed?

These well-known names are showing signs of either bullish or bearish reversal patterns.

Edwards Lifesciences Takes Over #37 Spot From Vertex Pharmaceuticals

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Edwards Lifesciences Corp has taken over the #37 spot from Vertex Pharmaceuticals, Inc. , according to ETF Channel.

Regions Financial, Edwards Lifesciences: 'Mad Money' Lightning Round

Regions Financial, Edwards Lifesciences: 'Mad Money' Lightning Round

Jim Cramer focuses on Regions Financial, Edwards Lifesciences, Align Technology, Applied Materials, Qualys, HEICO and more.

Not Thankful for Fridays: Cramer's 'Mad Money' Recap (Friday 4/20/18)

Not Thankful for Fridays: Cramer's 'Mad Money' Recap (Friday 4/20/18)

Jim Cramer says analysts and trade woes put a damper on buying ahead of the weekend. So let's get the game plan for next week.

3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback

3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback

Large-cap healthcare stocks, especially those in the medical technology sector, are one of the biggest losers in the recent market selloff.

Edwards Lifesciences Achieves #54 Analyst Rank, Surpassing Snap-On

Edwards Lifesciences Achieves #54 Analyst Rank, Surpassing Snap-On

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Edwards Lifesciences Corp has taken over the #54 spot from Snap-On, Inc. , according to ETF Channel.

Cramer: 10 Points to Consider

Cramer: 10 Points to Consider

Don't worry about missing anything, we haven't solved the bond conundrum and the evidence says we get to 3% with selloffs on the way.

7 Investment Themes You Can't Afford to Miss for 2018

7 Investment Themes You Can't Afford to Miss for 2018

The 'winning formula' for this year focuses on growth, size and foreign stocks, Jefferies says.

Marvell Technology, Albemarle, Dominion Energy: 'Mad Money' Lightning Round

Marvell Technology, Albemarle, Dominion Energy: 'Mad Money' Lightning Round

Jim Cramer is bullish on Marvell Technology, Albemarle, Dominion Energy, Best Buy, Houlihan Lokey.

Consumers Are Ready to Spend: Cramer's 'Mad Money' Recap (Tuesday 1/9/18)

Consumers Are Ready to Spend: Cramer's 'Mad Money' Recap (Tuesday 1/9/18)

Jim Cramer explains why some retailers are doing so well and how investors can take advantage of the opportunities.

What it Takes to Power This Bull: Cramer's 'Mad Money' Recap (Thursday 11/30/17)

What it Takes to Power This Bull: Cramer's 'Mad Money' Recap (Thursday 11/30/17)

Lose the cynicism or you might miss the move. Jim Cramer outlines the reasons for these gains and why investors need to watch them.

Medtronic's Strong Q1 Helps Send Healthcare Stocks Higher

Medtronic's Strong Q1 Helps Send Healthcare Stocks Higher

The Health Care SPDR ETF (XLV) was rising nearly 1% in afternoon trading on Tuesday, boosted in part, by solid results from medical equipment company Medtronic.

TheStreet Quant Rating: B (Buy)